Dr. Sanacora is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
34 Park St
Cnru At Cmhc
New Haven, CT 06519Phone+1 203-974-7560- Is this information wrong?
Summary
- Dr. Sanacora completed an NIH sponsored Medical Scientist Training Program at the State University New York at Stony Brook, earning his Ph.D. in Physiology and Biophysics in 1992 and his M.D. degree in 1994. He then moved to Yale University where he completed the Clinical Neuroscientist Training Program Residency in the Department of Psychiatry, and an NIH funded Neuroimaging Scientist Training Program Fellowship. He is currently a Professor of Psychiatry at Yale and the Director of the Yale Depression Research Program. Dr. Sanacora’s work is concentrated largely on elucidating the pathophysiological mechanisms associated with mood and other neuropsychiatric disorders. His basic science laboratory explores the effects of chronic stress on cellular biology and behavior, and examines the molecular, cellular and behavioral effects of newly developed treatment strategies. His clinical laboratory employs novel imaging methodologies and biomarker assays to investigate the pathophysiology of neuropsychiatric disorders. In addition, he has served as principle investigator on several early phase clinical trials designed to test the efficacy and mechanisms of action of newly developed therapeutic agents. Reflecting his contributions to the field, Dr. Sanacora was elected a Fellow of the American College of Neuropsychopharmacology in 2012. He has also received the Anna-Monkia Stiftung international award for the investigation of the biological substrate and functional disturbances of depression in 2009 and the Joel Elkes Research Award for Outstanding contributions to Psychopharmacology from the American College of Neuropsychopharmacology in 2011.
Education & Training
- Yale-New Haven Medical CenterResidency, Psychiatry, 1994 - 1998
- Stony Brook University Health Sciences Center School of MedicineClass of 1994
Certifications & Licensure
- CT State Medical License 1996 - 2024
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Ketamine for the Treatment of Depression in Parkinson's Disease Start of enrollment: 2021 Nov 23
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsThe Rapidly Shifting Ketamine Landscape in the US.Palamar, J., Wilkinson, S., Sanacora, G.> ;JAMA Psychiatry. 2024 Mar 1
- 2 citationsKetamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments.John H Krystal, Alfred P Kaye, Sarah Jefferson, Matthew J Girgenti, Samuel T Wilkinson, Gerard Sanacora, Irina Esterlis> ;Proceedings of the National Academy of Sciences of the United States of America. 2023 Dec 5
- Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders.Taeho Greg Rhee, Pasha A Davoudian, Gerard Sanacora, Samuel T Wilkinson> ;Drug Discovery Today. 2023 Dec 1
- Join now to see all
Press Mentions
- DEA Shuts down Telehealth Ketamine PrescriberMay 11th, 2023
- Ketamine: Handle with CareApril 10th, 2023
- The Cause of Depression Is Probably Not What You ThinkJanuary 26th, 2023
- Join now to see all
Hospital Affiliations
- Yale-New Haven HospitalNew Haven, Connecticut
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: